This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Shionogi Company Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Goro Kominami: Innovator in Monoclonal Antibody Development
Introduction
Goro Kominami is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on creating innovative solutions that can have a profound impact on medical science.
Latest Patents
Goro Kominami holds a patent for a monoclonal antibody to soluble LOX-1. This invention aims to provide a monoclonal antibody that specifically recognizes human soluble LOX-1, with a dissociation constant (Kd) for human soluble LOX-1 of 1×10(M) or less. The antibody is produced from a hybridoma prepared through a detailed method involving immunization, cell collection, fusion, and selection processes.
Career Highlights
Kominami is associated with Shionogi Company Limited, where he applies his expertise in antibody development. His innovative approach has led to advancements in the understanding and treatment of various medical conditions.
Collaborations
He collaborates with esteemed colleagues such as Masahiro Nakamura and Hideki Ohta, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Goro Kominami's work in monoclonal antibody development exemplifies the spirit of innovation in biotechnology. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile